ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Virus-like Particle Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18N12945
Home | Market Reports | Science| Chemistry
Global Virus like Particle Market Research Report 2023
BUY CHAPTERS

Global Virus-like Particle Market Research Report 2025

Code: QYRE-Auto-18N12945
Report
May 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
The Native Antigen Company
Creative Biostructure
Creative-Biolabs
Leadgene Biomedical
Abcam
ACROBiosystems
GenTarget
VectorBuilder

Virus-like Particle Market Size

The global market for Virus-like Particle was valued at US$ 381 million in the year 2024 and is projected to reach a revised size of US$ 682 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Virus-like Particle Market

Virus-like Particle Market

Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Virus-like Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virus-like Particle.
The Virus-like Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Virus-like Particle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virus-like Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Virus-like Particle Market Report

Report Metric Details
Report Name Virus-like Particle Market
Accounted market size in year US$ 381 million
Forecasted market size in 2031 US$ 682 million
CAGR 8.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Vaccine
  • Therapeutics
  • Bioimaging
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company The Native Antigen Company, Creative BioStructure, Creative Biolabs, Leadgene Biomedical, Abcam, ACROBiosystems, Gentarget, VectorBuilder
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Virus-like Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Virus-like Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Virus-like Particle Market growing?

Ans: The Virus-like Particle Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Virus-like Particle Market size in 2031?

Ans: The Virus-like Particle Market size in 2031 will be US$ 682 million.

Who are the main players in the Virus-like Particle Market report?

Ans: The main players in the Virus-like Particle Market are The Native Antigen Company, Creative BioStructure, Creative Biolabs, Leadgene Biomedical, Abcam, ACROBiosystems, Gentarget, VectorBuilder

What are the Application segmentation covered in the Virus-like Particle Market report?

Ans: The Applications covered in the Virus-like Particle Market report are Vaccine, Therapeutics, Bioimaging, Others

What are the Type segmentation covered in the Virus-like Particle Market report?

Ans: The Types covered in the Virus-like Particle Market report are E. coli, Yeast, Insect Cells, Others

Recommended Reports

Vaccine Technology

Vaccine Packaging

Drug Delivery

1 Virus-like Particle Market Overview
1.1 Product Definition
1.2 Virus-like Particle by Type
1.2.1 Global Virus-like Particle Market Value Comparison by Type (2024 VS 2031)
1.2.2 E. coli
1.2.3 Yeast
1.2.4 Insect Cells
1.2.5 Others
1.3 Virus-like Particle by Application
1.3.1 Global Virus-like Particle Market Value by Application (2024 VS 2031)
1.3.2 Vaccine
1.3.3 Therapeutics
1.3.4 Bioimaging
1.3.5 Others
1.4 Global Virus-like Particle Market Size Estimates and Forecasts
1.4.1 Global Virus-like Particle Revenue 2020-2031
1.4.2 Global Virus-like Particle Sales 2020-2031
1.4.3 Global Virus-like Particle Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Virus-like Particle Market Competition by Manufacturers
2.1 Global Virus-like Particle Sales Market Share by Manufacturers (2020-2025)
2.2 Global Virus-like Particle Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Virus-like Particle Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Virus-like Particle, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Virus-like Particle, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Virus-like Particle, Product Type & Application
2.7 Global Key Manufacturers of Virus-like Particle, Date of Enter into This Industry
2.8 Global Virus-like Particle Market Competitive Situation and Trends
2.8.1 Global Virus-like Particle Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Virus-like Particle Players Market Share by Revenue
2.8.3 Global Virus-like Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Virus-like Particle Market Scenario by Region
3.1 Global Virus-like Particle Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Virus-like Particle Sales by Region: 2020-2031
3.2.1 Global Virus-like Particle Sales by Region: 2020-2025
3.2.2 Global Virus-like Particle Sales by Region: 2026-2031
3.3 Global Virus-like Particle Revenue by Region: 2020-2031
3.3.1 Global Virus-like Particle Revenue by Region: 2020-2025
3.3.2 Global Virus-like Particle Revenue by Region: 2026-2031
3.4 North America Virus-like Particle Market Facts & Figures by Country
3.4.1 North America Virus-like Particle Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Virus-like Particle Sales by Country (2020-2031)
3.4.3 North America Virus-like Particle Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Virus-like Particle Market Facts & Figures by Country
3.5.1 Europe Virus-like Particle Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Virus-like Particle Sales by Country (2020-2031)
3.5.3 Europe Virus-like Particle Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Virus-like Particle Market Facts & Figures by Region
3.6.1 Asia Pacific Virus-like Particle Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Virus-like Particle Sales by Region (2020-2031)
3.6.3 Asia Pacific Virus-like Particle Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Virus-like Particle Market Facts & Figures by Country
3.7.1 Latin America Virus-like Particle Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Virus-like Particle Sales by Country (2020-2031)
3.7.3 Latin America Virus-like Particle Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Virus-like Particle Market Facts & Figures by Country
3.8.1 Middle East and Africa Virus-like Particle Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Virus-like Particle Sales by Country (2020-2031)
3.8.3 Middle East and Africa Virus-like Particle Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Virus-like Particle Sales by Type (2020-2031)
4.1.1 Global Virus-like Particle Sales by Type (2020-2025)
4.1.2 Global Virus-like Particle Sales by Type (2026-2031)
4.1.3 Global Virus-like Particle Sales Market Share by Type (2020-2031)
4.2 Global Virus-like Particle Revenue by Type (2020-2031)
4.2.1 Global Virus-like Particle Revenue by Type (2020-2025)
4.2.2 Global Virus-like Particle Revenue by Type (2026-2031)
4.2.3 Global Virus-like Particle Revenue Market Share by Type (2020-2031)
4.3 Global Virus-like Particle Price by Type (2020-2031)
5 Segment by Application
5.1 Global Virus-like Particle Sales by Application (2020-2031)
5.1.1 Global Virus-like Particle Sales by Application (2020-2025)
5.1.2 Global Virus-like Particle Sales by Application (2026-2031)
5.1.3 Global Virus-like Particle Sales Market Share by Application (2020-2031)
5.2 Global Virus-like Particle Revenue by Application (2020-2031)
5.2.1 Global Virus-like Particle Revenue by Application (2020-2025)
5.2.2 Global Virus-like Particle Revenue by Application (2026-2031)
5.2.3 Global Virus-like Particle Revenue Market Share by Application (2020-2031)
5.3 Global Virus-like Particle Price by Application (2020-2031)
6 Key Companies Profiled
6.1 The Native Antigen Company
6.1.1 The Native Antigen Company Company Information
6.1.2 The Native Antigen Company Description and Business Overview
6.1.3 The Native Antigen Company Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.1.4 The Native Antigen Company Virus-like Particle Product Portfolio
6.1.5 The Native Antigen Company Recent Developments/Updates
6.2 Creative BioStructure
6.2.1 Creative BioStructure Company Information
6.2.2 Creative BioStructure Description and Business Overview
6.2.3 Creative BioStructure Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Creative BioStructure Virus-like Particle Product Portfolio
6.2.5 Creative BioStructure Recent Developments/Updates
6.3 Creative Biolabs
6.3.1 Creative Biolabs Company Information
6.3.2 Creative Biolabs Description and Business Overview
6.3.3 Creative Biolabs Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Creative Biolabs Virus-like Particle Product Portfolio
6.3.5 Creative Biolabs Recent Developments/Updates
6.4 Leadgene Biomedical
6.4.1 Leadgene Biomedical Company Information
6.4.2 Leadgene Biomedical Description and Business Overview
6.4.3 Leadgene Biomedical Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Leadgene Biomedical Virus-like Particle Product Portfolio
6.4.5 Leadgene Biomedical Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Company Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abcam Virus-like Particle Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 ACROBiosystems
6.6.1 ACROBiosystems Company Information
6.6.2 ACROBiosystems Description and Business Overview
6.6.3 ACROBiosystems Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ACROBiosystems Virus-like Particle Product Portfolio
6.6.5 ACROBiosystems Recent Developments/Updates
6.7 Gentarget
6.7.1 Gentarget Company Information
6.7.2 Gentarget Description and Business Overview
6.7.3 Gentarget Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Gentarget Virus-like Particle Product Portfolio
6.7.5 Gentarget Recent Developments/Updates
6.8 VectorBuilder
6.8.1 VectorBuilder Company Information
6.8.2 VectorBuilder Description and Business Overview
6.8.3 VectorBuilder Virus-like Particle Sales, Revenue and Gross Margin (2020-2025)
6.8.4 VectorBuilder Virus-like Particle Product Portfolio
6.8.5 VectorBuilder Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Virus-like Particle Industry Chain Analysis
7.2 Virus-like Particle Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Virus-like Particle Production Mode & Process Analysis
7.4 Virus-like Particle Sales and Marketing
7.4.1 Virus-like Particle Sales Channels
7.4.2 Virus-like Particle Distributors
7.5 Virus-like Particle Customer Analysis
8 Virus-like Particle Market Dynamics
8.1 Virus-like Particle Industry Trends
8.2 Virus-like Particle Market Drivers
8.3 Virus-like Particle Market Challenges
8.4 Virus-like Particle Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
The Native Antigen Company
Creative Biostructure
Creative-Biolabs
Leadgene Biomedical
Abcam
ACROBiosystems
GenTarget
VectorBuilder
List of Tables
 Table 1. Global Virus-like Particle Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Virus-like Particle Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Virus-like Particle Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Virus-like Particle Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Virus-like Particle Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Virus-like Particle Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Virus-like Particle Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Virus-like Particle Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Virus-like Particle, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Virus-like Particle, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Virus-like Particle, Product Type & Application
 Table 12. Global Key Manufacturers of Virus-like Particle, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Virus-like Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particle as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Virus-like Particle Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Virus-like Particle Sales by Region (2020-2025) & (K Units)
 Table 18. Global Virus-like Particle Sales Market Share by Region (2020-2025)
 Table 19. Global Virus-like Particle Sales by Region (2026-2031) & (K Units)
 Table 20. Global Virus-like Particle Sales Market Share by Region (2026-2031)
 Table 21. Global Virus-like Particle Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Virus-like Particle Revenue Market Share by Region (2020-2025)
 Table 23. Global Virus-like Particle Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Virus-like Particle Revenue Market Share by Region (2026-2031)
 Table 25. North America Virus-like Particle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Virus-like Particle Sales by Country (2020-2025) & (K Units)
 Table 27. North America Virus-like Particle Sales by Country (2026-2031) & (K Units)
 Table 28. North America Virus-like Particle Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Virus-like Particle Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Virus-like Particle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Virus-like Particle Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Virus-like Particle Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Virus-like Particle Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Virus-like Particle Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Virus-like Particle Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Virus-like Particle Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Virus-like Particle Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Virus-like Particle Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Virus-like Particle Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Virus-like Particle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Virus-like Particle Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Virus-like Particle Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Virus-like Particle Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Virus-like Particle Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Virus-like Particle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Virus-like Particle Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Virus-like Particle Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Virus-like Particle Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Virus-like Particle Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Virus-like Particle Sales (K Units) by Type (2020-2025)
 Table 51. Global Virus-like Particle Sales (K Units) by Type (2026-2031)
 Table 52. Global Virus-like Particle Sales Market Share by Type (2020-2025)
 Table 53. Global Virus-like Particle Sales Market Share by Type (2026-2031)
 Table 54. Global Virus-like Particle Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Virus-like Particle Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Virus-like Particle Revenue Market Share by Type (2020-2025)
 Table 57. Global Virus-like Particle Revenue Market Share by Type (2026-2031)
 Table 58. Global Virus-like Particle Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Virus-like Particle Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Virus-like Particle Sales (K Units) by Application (2020-2025)
 Table 61. Global Virus-like Particle Sales (K Units) by Application (2026-2031)
 Table 62. Global Virus-like Particle Sales Market Share by Application (2020-2025)
 Table 63. Global Virus-like Particle Sales Market Share by Application (2026-2031)
 Table 64. Global Virus-like Particle Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Virus-like Particle Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Virus-like Particle Revenue Market Share by Application (2020-2025)
 Table 67. Global Virus-like Particle Revenue Market Share by Application (2026-2031)
 Table 68. Global Virus-like Particle Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Virus-like Particle Price (US$/Unit) by Application (2026-2031)
 Table 70. The Native Antigen Company Company Information
 Table 71. The Native Antigen Company Description and Business Overview
 Table 72. The Native Antigen Company Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. The Native Antigen Company Virus-like Particle Product
 Table 74. The Native Antigen Company Recent Developments/Updates
 Table 75. Creative BioStructure Company Information
 Table 76. Creative BioStructure Description and Business Overview
 Table 77. Creative BioStructure Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Creative BioStructure Virus-like Particle Product
 Table 79. Creative BioStructure Recent Developments/Updates
 Table 80. Creative Biolabs Company Information
 Table 81. Creative Biolabs Description and Business Overview
 Table 82. Creative Biolabs Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Creative Biolabs Virus-like Particle Product
 Table 84. Creative Biolabs Recent Developments/Updates
 Table 85. Leadgene Biomedical Company Information
 Table 86. Leadgene Biomedical Description and Business Overview
 Table 87. Leadgene Biomedical Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Leadgene Biomedical Virus-like Particle Product
 Table 89. Leadgene Biomedical Recent Developments/Updates
 Table 90. Abcam Company Information
 Table 91. Abcam Description and Business Overview
 Table 92. Abcam Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Abcam Virus-like Particle Product
 Table 94. Abcam Recent Developments/Updates
 Table 95. ACROBiosystems Company Information
 Table 96. ACROBiosystems Description and Business Overview
 Table 97. ACROBiosystems Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. ACROBiosystems Virus-like Particle Product
 Table 99. ACROBiosystems Recent Developments/Updates
 Table 100. Gentarget Company Information
 Table 101. Gentarget Description and Business Overview
 Table 102. Gentarget Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Gentarget Virus-like Particle Product
 Table 104. Gentarget Recent Developments/Updates
 Table 105. VectorBuilder Company Information
 Table 106. VectorBuilder Description and Business Overview
 Table 107. VectorBuilder Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. VectorBuilder Virus-like Particle Product
 Table 109. VectorBuilder Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Virus-like Particle Distributors List
 Table 113. Virus-like Particle Customers List
 Table 114. Virus-like Particle Market Trends
 Table 115. Virus-like Particle Market Drivers
 Table 116. Virus-like Particle Market Challenges
 Table 117. Virus-like Particle Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Virus-like Particle
 Figure 2. Global Virus-like Particle Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Virus-like Particle Market Share by Type: 2024 & 2031
 Figure 4. E. coli Product Picture
 Figure 5. Yeast Product Picture
 Figure 6. Insect Cells Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Virus-like Particle Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Virus-like Particle Market Share by Application: 2024 & 2031
 Figure 10. Vaccine
 Figure 11. Therapeutics
 Figure 12. Bioimaging
 Figure 13. Others
 Figure 14. Global Virus-like Particle Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Virus-like Particle Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Virus-like Particle Sales (2020-2031) & (K Units)
 Figure 17. Global Virus-like Particle Average Price (US$/Unit) & (2020-2031)
 Figure 18. Virus-like Particle Report Years Considered
 Figure 19. Virus-like Particle Sales Share by Manufacturers in 2024
 Figure 20. Global Virus-like Particle Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Virus-like Particle Players: Market Share by Revenue in Virus-like Particle in 2024
 Figure 22. Virus-like Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Virus-like Particle Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Virus-like Particle Sales Market Share by Country (2020-2031)
 Figure 25. North America Virus-like Particle Revenue Market Share by Country (2020-2031)
 Figure 26. United States Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Virus-like Particle Sales Market Share by Country (2020-2031)
 Figure 29. Europe Virus-like Particle Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Virus-like Particle Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Virus-like Particle Revenue Market Share by Region (2020-2031)
 Figure 37. China Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Virus-like Particle Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Virus-like Particle Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Virus-like Particle Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Virus-like Particle Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Virus-like Particle Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Virus-like Particle by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Virus-like Particle by Type (2020-2031)
 Figure 56. Global Virus-like Particle Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Virus-like Particle by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Virus-like Particle by Application (2020-2031)
 Figure 59. Global Virus-like Particle Price (US$/Unit) by Application (2020-2031)
 Figure 60. Virus-like Particle Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Virus like Particles VLPs Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Virus like Particle VLP Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VLP based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Virus like Particles VLPs Delivery System Market Research Report 2024
Global Virus like Particle VLP Vaccines Market Research Report 2024
Global Lipid Nanoparticles LNP Market Research Report 2024
Global Pseudovirus Products Market Research Report 2024
Global Lipid Contract Manufacturing Market Research Report 2024
Global Virus Like Particles Market Research Report 2024
Global LNP Synthesis System Market Research Report 2024
Global Polymers for Medical Devices Market Insights Forecast to 2030
Global Polymer Nanoparticles PNP Formulation Development Market Research Report 2024
VLP Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lentivirus Particle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Nanoparticle Synthesis System Market Research Report 2025
Global Lipid Nanoparticle LNP Development Service Market Research Report 2025
Global Research Grade Viral Vector Packaging Service Market Research Report 2025
Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024
Global Polymers in Medical Devices Market Research Report 2025
Nanocarrier Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Ion-Exchange Chromatography Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30T5793
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Electron Paramagnetic Resonance (EPR) Spectroscopy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10S3363
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global C13 Isotope Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37I19795
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Medium-Pressure Chromatography Column Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3C19905
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions